Consort Medical PLC | Ownership
Companies that own Consort Medical PLC
OppenheimerFunds, Inc.
2,856,109
5.8%
0
0.03%
07/02/2018
Polar Capital LLP
2,728,523
5.54%
4,070
0.09%
07/18/2018
Montanaro Asset Management Ltd.
2,613,000
5.3%
-264,900
1.72%
07/13/2018
Schroder Investment Management Ltd.
2,459,540
4.99%
-1,104,210
0.02%
08/22/2018
Artemis Investment Management LLP
2,208,987
4.48%
315,206
0.11%
07/02/2018
Invesco Asset Management Ltd.
2,144,474
4.34%
324,020
0.04%
07/17/2018
BlackRock Investment Management (UK) Ltd.
2,143,813
4.34%
1,074,814
0.01%
08/06/2018
Legal & General Investment Management Ltd.
1,776,265
3.6%
-284,000
0.01%
07/31/2018
Kempen Capital Management NV
1,746,988
3.54%
1,646,988
0.48%
08/03/2018
BAE Systems Pension Funds Investment Management Ltd.
1,604,109
3.25%
-132,891
0.68%
07/23/2018
| Address |
Breakspear Park
Hemel Hempstead Hertfordshire HP2 4TZ
United Kingdom
|
|
Employees
|
- |
| Website |
http://consortmedical.com |
| Updated |
07/08/2019 |
| Consort Medical Plc engages in the design, development, manufacture, and sale of medical drug delivery devices. It operates through two segments: Bespak and Aesica. The Bespak segment develops and produces drug delivery devices, which serves pharmaceutical companies with inhaler and auto-injector technologies. |
